InspireMD Inc.
Last updated September 27, 2026
Organization details
- Legal name
- InspireMD Inc.
- Former names
- Saguaro Resources, Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 3841 — Surgical & Medical Instruments & Apparatus
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Miami
- Headquarters state / province
- Florida
- Headquarters country
- Israel
- Fiscal year end
- December
- Ticker symbol
- NSPR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001433607
- EIN
- 26-2123838
Board of directors
-
Danny L. Dearen · DirectorSince 2025
-
Gary S. Roubin · DirectorSince 2023
-
Kathryn Arnold · DirectorSince 2023
-
Marvin Slosman · Director · CEO and PresidentSince 2023
-
Michael Berman · DirectorSince 2023
-
Paul Stuka · DirectorSince 2023
-
Raymond W. Cohen · DirectorSince 2025
-
Scott R. Ward · DirectorSince 2024
-
Thomas J. Kester · DirectorSince 2023
Chief executives
Marvin Slosman
· CEO and President
Dates unknown
Director election results
Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
84.8%
-
84.8%
-
93.6%
Board connections
4 of this board's directors also sit on 5 other boards.
- via Danny L. Dearen
- via Marvin Slosman
- via Raymond W. Cohen
- via Scott R. Ward
- via Raymond W. Cohen
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $425,164
- 15 purchases by 4 insiders
- Sold, last 12 months
- $126,870
- 12 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 27, 2026 | Paul Stuka Director | Open-market purchase | +20,000 | $0.88 | $17,600 |
| May 19, 2026 | Gleason Shane Thomas Officer (Chief Commercial Officer) | Open-market sale | −22,778 | $1.01 | $23,006 |
| May 14, 2026 | Paul Stuka Director | Open-market purchase | +5,000 | $1.15 | $5,750 |
| May 13, 2026 | Paul Stuka Director | Open-market purchase | +10,000 | $1.16 | $11,600 |
| May 12, 2026 | Marvin Slosman Director, Officer (CEO and President) | Open-market purchase | +21,000 | $1.20 | $25,200 |
| May 11, 2026 | Paul Stuka Director | Open-market purchase | +10,000 | $1.19 | $11,900 |
| May 8, 2026 | Paul Stuka Director | Open-market purchase | +65,626 | $1.16 | $76,126 |
| May 7, 2026 | Gary S. Roubin Director | Open-market purchase | +90,000 | $1.18 | $106,200 |
| May 7, 2026 | Scott R. Ward Director | Open-market purchase | +73,255 | $1.15 | $84,243 |
| May 7, 2026 | Paul Stuka Director | Open-market purchase | +6,378 | $1.15 | $7,335 |
| May 6, 2026 | Scott R. Ward Director | Open-market purchase | +15,995 | $1.15 | $18,394 |
| May 6, 2026 | Paul Stuka Director | Open-market purchase | +1,517 | $1.12 | $1,699 |
| Feb 2, 2026 | Gleason Shane Thomas Officer (Chief Commercial Officer) | Open-market sale | −2,000 | $1.60 | $3,200 |
| Feb 2, 2026 | Gleason Shane Thomas Officer (Chief Commercial Officer) | Open-market sale | −2,941 | $1.59 | $4,676 |
| Jan 30, 2026 | Gleason Shane Thomas Officer (Chief Commercial Officer) | Open-market sale | −2,900 | $1.63 | $4,727 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.